Market Cap | 333.42M | P/E | 54.06 | EPS this Y | 44.00% | Ern Qtrly Grth | 5.70% |
Income | 10.33M | Forward P/E | 18.80 | EPS next Y | 16.70% | 50D Avg Chg | -8.00% |
Sales | 194.04M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -1.00% |
Dividend | N/A | Price/Book | 3.31 | EPS next 5Y | - | 52W High Chg | -28.00% |
Recommedations | 2.00 | Quick Ratio | 1.06 | Shares Outstanding | 38.82M | 52W Low Chg | 58.00% |
Insider Own | 12.69% | ROA | 7.16% | Shares Float | 32.01M | Beta | 1.36 |
Inst Own | 62.40% | ROE | 9.55% | Shares Shorted/Prior | 396.66K/202.48K | Price | 8.65 |
Gross Margin | 61.11% | Profit Margin | 5.32% | Avg. Volume | 216,670 | Target Price | 15.38 |
Oper. Margin | 4.78% | Earnings Date | Aug 7 | Volume | 78,141 | Change | -1.48% |
Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
RBC Capital | Outperform | Nov 3, 21 |
RBC Capital | Outperform | Mar 5, 21 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Kaushal Nitin | Director Director | Mar 17 | Sell | 13.43 | 12,087 | 162,328 | 102,524 | 03/20/23 |
Kaushal Nitin | Director Director | Mar 17 | Option | 2.27 | 12,087 | 27,437 | 114,611 | 03/20/23 |
Smokoff Timothy | Director Director | Dec 21 | Sell | 10.25 | 25,900 | 265,475 | 67,332 | 12/23/22 |
Smokoff Timothy | Director Director | Dec 21 | Option | 2.27 | 25,900 | 58,793 | 81,332 | 12/23/22 |